Ausgabe 1/2018
Inhalt (32 Artikel)
WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia
Hongtao Liu, Yuanyuan Zha, Noura Choudhury, Gregory Malnassy, Noreen Fulton, Margaret Green, Jae-Hyun Park, Yusuke Nakamura, Richard A. Larson, Andres M. Salazar, Olatoyosi Odenike, Thomas F. Gajewski, Wendy Stock
Complete response in advanced breast cancer patient treated with a combination of capecitabine, oral vinorelbine and dasatinib
V. Sgroi, M. Bassanelli, M. Roberto, E. Iannicelli, R. Porrini, P. Pellegrini, A. Tafuri, P. Marchetti
Deep sustained response to daratumumab monotherapy associated with T-cell expansion in triple refractory myeloma
Saad Z. Usmani, Imran Khan, Christopher Chiu, David Foureau, Lawrence J. Druhan, Katherine Rigby, Tineke Casneuf, A. Kate Sasser
Cost-effectiveness of nivolumab in patients with advanced renal cell carcinoma treated in the United States
Charles McCrea, Sukhvinder Johal, Shuo Yang, Justin Doan
Potential added value of a RT-qPCR method of SOX 11 expression, in the context of a multidisciplinary diagnostic assessment of B cell malignancies
Julien Magne, Alizée Jenvrin, Adrien Chauchet, Olivier Casasnovas, Anne Donzel, Laurence Jego, Bernard Aral, Julien Guy, Nathalie Nadal, Dewi Vernerey, Patrick Callier, Francine Garnache-Ottou, Christophe Ferrand
Aplastic anemia secondary to nivolumab and ipilimumab in a patient with metastatic melanoma: a case report
D. E. Meyers, W. F. Hill, A. Suo, V. Jimenez-Zepeda, T. Cheng, N. A. Nixon
PAN3–PSMA2 fusion resulting from a novel t(7;13)(p14;q12) chromosome translocation in a myelodysplastic syndrome that evolved into acute myeloid leukemia
Ioannis Panagopoulos, Ludmila Gorunova, Hege Kilen Andersen, Astrid Bergrem, Anders Dahm, Kristin Andersen, Francesca Micci, Sverre Heim
Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration
Magnus Aassved Hjort, Håkon Hov, Pegah Abdollahi, Esten Nymoen Vandsemb, Unn-Merete Fagerli, Bendik Lund, Tobias Schmidt Slørdahl, Magne Børset, Torstein Baade Rø
Correlation of plasma concentration and adverse effects of bosutinib: standard dose or dose-escalation regimens of bosutinib treatment for patients with chronic myeloid leukemia
Akiko Mita, Maiko Abumiya, Masatomo Miura, Takenori Niioka, Saori Takahashi, Tomoko Yoshioka, Yoshihiro Kameoka, Naoto Takahashi
An integrated view of the role of miR-130b/301b miRNA cluster in prostate cancer
Rafael Sebastián Fort, Cecilia Mathó, Carolina Oliveira-Rizzo, Beatriz Garat, José Roberto Sotelo-Silveira, María Ana Duhagon
Conservative management of nivolumab-induced pericardial effusion: a case report and review of literature
Shagufta Shaheen, Hamid Mirshahidi, Gayathri Nagaraj, Chung-Tsen Hsueh
Phase 2 study of everolimus for relapsed or refractory classical Hodgkin lymphoma
Patrick B. Johnston, Lauren C. Pinter-Brown, Ghulam Warsi, Kristen White, Radhakrishnan Ramchandren
Understanding metabolic changes in aging bone marrow
Kwasi M. Connor, Young Hsu, Pardeep Kumar Aggarwal, Stephen Capone, Anthony R. Colombo, Giridharan Ramsingh
Bone marrow transplant-associated thrombotic microangiopathy without peripheral blood schistocytes: a case report and review of the literature
Eric Wirtschafter, Christine VanBeek, Yuliya Linhares
Bullous hemorrhagic dermatosis is an under-recognized side effect of full dose low-molecular weight heparin: a case report and review of the literature
Armand Russo, Susanna Curtis, Raisa Balbuena-Merle, Roxanne Wadia, Ellice Wong, Herta H. Chao
Are patients with high-risk polycythemia vera receiving cytoreductive medications? A retrospective analysis of real-world data
Dilan Paranagama, Philomena Colucci, Kristin A. Evans, Machaon Bonafede, Shreekant Parasuraman
Emerging therapies in advanced hepatocellular carcinoma
Sowmini Medavaram, Yue Zhang
A randomized placebo-controlled phase II study of clarithromycin or placebo combined with VCD induction therapy prior to high-dose melphalan with stem cell support in patients with newly diagnosed multiple myeloma
Henrik Gregersen, Trung Do, Ida Bruun Kristensen, Ulf Christian Frølund, Niels Frost Andersen, Lene Kongsgaard Nielsen, Christen Lykkegaard Andersen, Tobias Wirenfeldt Klausen, Annette Juul Vangsted, Niels Abildgaard
The association of HLA-C alleles with multiple myeloma in Chinese patients
Xiaojing Wang, Gang An, Jiying Wang, Yan Zhang, Qinghua Li, Hui wei, Lugui Qiu, Kun Ru
Metastatic squamous cell carcinoma of the skin with clinical response to lapatinib
John D. Strickley, Aaron C. Spalding, M. Tye Haeberle, Timothy Brown, Don A. Stevens, Jae Jung
Personalized prescription of tyrosine kinase inhibitors in unresectable metastatic cholangiocarcinoma
Elena V. Poddubskaya, Madina P. Baranova, Daria O. Allina, Philipp Y. Smirnov, Eugene A. Albert, Alexey P. Kirilchev, Alexey A. Aleshin, Marina I. Sekacheva, Maria V. Suntsova
Clinical confirmation to demonstrate similarity for a biosimilar pegfilgrastim: a 3-way randomized equivalence study for a proposed biosimilar pegfilgrastim versus US-licensed and EU-approved reference products in breast cancer patients receiving myelosuppressive chemotherapy
Kalpna Desai, Priya Misra, Sanyukta Kher, Nirmesh Shah
Temporality of heparin-induced antibodies: a retrospective study in outpatients undergoing hemodialysis on unfractionated heparin
Satish Maharaj, Simone Chang, Karan Seegobin, James Morales, Agnes Aysola, Fauzia Rana, Marwan Shaikh
Mechanisms for estrogen receptor expression in human cancer
Hui Hua, Hongying Zhang, Qingbin Kong, Yangfu Jiang
Induction of anti-leukemic responses by stimulation of leukemic CD3+ cells with allogeneic stimulator cells
Alejandro Pando, John L. Reagan, Martha Nevola, Loren D. Fast
Early detection of transformation to BPDCN in a patient with MDS
Kamal Chamoun, Sanam Loghavi, Naveen Pemmaraju, Marina Konopleva, Michael Kroll, Madeleine Nguyen-Cao, Marisa Hornbaker, Courtney D. DiNardo, Tapan Kadia, Jeffrey Jorgensen, Michael Andreeff, Shimin Hu, Christopher B. Benton
Daratumumab binds to mobilized CD34+ cells of myeloma patients in vitro without cytotoxicity or impaired progenitor cell growth
Xun Ma, Sandy W. Wong, Ping Zhou, Chakra P. Chaulagain, Parul Doshi, Andreas K. Klein, Kellie Sprague, Adin Kugelmass, Denis Toskic, Melissa Warner, Kenneth B. Miller, Lisa Lee, Cindy Varga, Raymond L. Comenzo
The role of neoantigen in immune checkpoint blockade therapy
Ming Yi, Shuang Qin, Weiheng Zhao, Shengnan Yu, Qian Chu, Kongming Wu
Early vs. late MRD response- and risk-based treatment intensification of childhood acute lymphoblastic leukemia: a prospective pilot study from Saudi Arabia
Wasil Jastaniah, Naglla Elimam, Khalid Abdalla, Aeshah A. AlAzmi, Aml M. Elgaml, Ahmad Alkassar, Mustafa Daghistani, Sami Felimban
Organoid technology in disease modelling, drug development, personalized treatment and regeneration medicine
Hanxiao Xu, Ying Jiao, Shuang Qin, Weiheng Zhao, Qian Chu, Kongming Wu
The epidemiology and clinical characteristics of myeloproliferative neoplasms in Malaysia
Yee Yee Yap, Kian Boon Law, Jameela Sathar, Ngee Siang Lau, Ai Sim Goh, Teng Keat Chew, Soo Min Lim, Padmini Menon, Yong Khee Guan, Azlan Bin Husin, Lily Lee Lee Wong, Lee Ping Chew, Sinari Salleh, Kim Yen Goh, Kin Wah Leong, Sen Mui Tan, Tee Chuan Ong, Su Hong Lim, See Guan Toh, Xavier Sim Yoon Han, Syed Carlo Edmund, Jenq Tzong Tan, Kian Meng Chang
Methylome of human senescent hematopoietic progenitors
Stephen Capone, Anthony R. Colombo, Benjamin K. Johnson, Tim J. Triche Jr., Giridharan Ramsingh